Oncolytics Biotech Inc (ONCY) Stock Analysis

Oncolytics Biotech Inc (ONCY) is a publicly traded company in the HEALTHCARE sector. It trades at $0.93, carries a market capitalization of $126.52M. This page summarizes the public market data, fundamentals, and frequently asked questions for ONCY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.93
• Market Cap: $126.52M
• EPS: $-0.32
• 52-Week High: $1.51
• 52-Week Low: $0.33

Market Sentiment

Oncolytics Biotech Inc currently has a Bullish sentiment score of 0.49.

About Oncolytics Biotech Inc

Oncolytics Biotech Inc. (ONCY) is a Calgary-based clinical-stage biopharmaceutical company focused on pioneering oncolytic virus therapies for cancer treatment. Its leading candidate, pelareorep, uniquely targets cancer cells while enhancing the body’s immune response against tumors. With a robust pipeline and ongoing clinical trials, Oncolytics aims to deliver innovative solutions for patients with a range of cancers. The company leverages strategic collaborations and a strong research backg...

GNG Research Analysis

GNG Research scores Oncolytics Biotech Inc (ONCY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ONCY.

Frequently Asked Questions

Does ONCY pay dividends?

Oncolytics Biotech Inc (ONCY) does not currently pay a regular dividend.

What is ONCY's market cap?

Oncolytics Biotech Inc (ONCY) has a market capitalization of $126.52M with a current stock price of $0.93.